Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleThe active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4+ T cell-priming capacity of dendritic cells.AuthorsPlatt, Andrew M.; Benson, Robert A.; McQueenie, Ross; Butcher, John P.; Braddock, Martin; Brewer, James M.; McInnes, Iain B.; Garside, PaulPublicationRheumatology, 2015, Vol 54, Issue 1, p169ISSN1462-0324Publication typeJournal Article